LianBio
LIANY · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $481,781 | $159,680 | $244,334 | $210,038 |
| - Cash | $438,584 | $103,457 | $104,056 | $102,333 |
| + Debt | $2,457 | $2,843 | $3,300 | $3,920 |
| Enterprise Value | $45,654 | $59,067 | $143,578 | $111,624 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$347 | -$300 | -$297 | -$323 |
| % Margin | – | – | – | – |
| EBITDA | $383,301 | -$23,154 | -$24,710 | -$23,238 |
| % Margin | – | – | – | – |
| Net Income | $383,733 | -$24,039 | -$21,621 | -$24,045 |
| % Margin | – | – | – | – |
| EPS Diluted | 3.55 | -0.22 | -0.2 | -0.22 |
| % Growth | 1,713.6% | -10% | 9.1% | – |
| Operating Cash Flow | $311,522 | -$15,861 | -$19,128 | -$17,598 |
| Capital Expenditures | -$147 | -$159 | -$50 | -$19 |
| Free Cash Flow | $311,375 | -$16,020 | -$19,177 | -$17,617 |